Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung cancer mutations and use of targeted agents in Hispanics.

Reviews on recent clinical trials - 1 Jan 2014

Cress W Douglas, Chiappori Alberto, Santiago Pedro, Muñoz-Antonia Teresita

Abstract excerpt

Hispanic/Latinos (H/L) are expected to grow to over 24% of the USA population by 2050 and lung cancer is the number one cause of cancer death among H/L men. Due to the information that is becoming available via genetic testing, lung cancer molecular profiling is allowing for increasing application of personalized lung cancer therapies. However, to benefit the most people, development of these therapies and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to DNA, Neoplasm
Share to EML4 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hispanic or Latino

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 25626064
DOI: 10.2174/1574887110666150127103555
PMCID: PMC4441412

Genes

EGFR
ALK
EML4
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lung cancer mutations and use of targeted agents in Hispanics.PMID 25626064Read ↗

Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis.Semantic proximity Read ↗

Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients.Semantic proximity Read ↗

EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma.Semantic proximity Read ↗

Lung adenocarcinoma biomarker incidence in Hispanic versus non-Hispanic white patients.Semantic proximity Read ↗

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumSemantic proximity Read ↗

Real-World Incidence of Anaplastic Lymphoma Kinase Alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles.Semantic proximity Read ↗

Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles.Semantic proximity Read ↗

Cancer Genes in Lung Cancer: Racial Disparities: Are There Any?Semantic proximity Read ↗

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox".Semantic proximity Read ↗

Comprehensive Characterization of Oncogenic Drivers in Asian Lung AdenocarcinomaSemantic proximity Read ↗

Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).Semantic proximity Read ↗

Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.